Abstract
Dose adjustment of direct oral anticoagulants (DOACs) is not required in the setting of acute PE treatment other than the contraindication in severe renal insufficiency. Prospective, multicenter cohort study to investigate the risk associated with prescription of non-recommended DOAC doses. The
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
